Amgen, AstraZeneca''s Tezspire for severe asthma gets approval in EU
The European Commission ((EC)) approved Amgen (AMGN) and AstraZeneca''s (AZN) Tezspire as an add-on maintenance therapy for patients 12 years and older with severe asthma who…
Amgen, AstraZeneca''s Tezspire for severe asthma gets approval in EU
The European Commission ((EC)) approved Amgen (AMGN) and AstraZeneca''s (AZN) Tezspire as an add-on maintenance therapy for patients 12 years and older with severe asthma who…